跳至主要内容
临床试验/ISRCTN18440098
ISRCTN18440098已完成未知

PRostate Evaluation for Clinically Important disease: Sampling using Image-guidance Or Not?

CL Clinical Trials Unit0 个研究点目标入组 500 人开始时间: 2015年4月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
500

研究概览

简要总结

2017 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/29025845 (added 09/08/2019) 2019 results in: https://www.ncbi.nlm.nih.gov/pubmed/29552975 (added 09/08/2019)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Men at least 18 years of age referred with clinical suspicion of prostate cancer who have been advised to have a prostate biopsy
  • 2. Serum PSA = 20ng/ml
  • 3. Suspected stage = T2 on rectal examination (organ-confined prostate cancer)
  • 4. Fit to undergo all procedures listed in protocol
  • 5. Able to provide written informed consent

排除标准

  • 1. Prior prostate biopsy
  • 2. Prior treatment for prostate cancer
  • 3. Contraindication to MRI
  • 4. Contraindication to prostate biopsy
  • 5. Men in whom artifact would reduce the quality of the MRI
  • 6. Previous hip replacement surgery, metallic hip replacement or extensive pelvic orthopaedic metal work
  • 7. Unfit to undergo any procedures listed in protocol

研究者

发起方
CL Clinical Trials Unit

相似试验

Magnetic resonance imaging-targeted biopsy compared... | 临床试验